Why Globe Life (GL) Stock Is Down Today

Globe Life (GL) is down 7.9% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is a negative post-earnings reaction after Globe Life cut its full-year 2026 earnings outlook and pointed to unexpected problems in its United American General Agency business. The sell-off appears to have intensified after Piper Sandler downgraded the stock, reinforcing investor concerns about medical claims volatility and the reliability of near-term earnings.

Details:

Globe Life reported third-quarter 2026 net income of $4.62 per diluted share, down from $4.73 a year earlier, while net operating income was $4.84 per diluted share.

The company lowered full-year 2026 earnings guidance to $15.35 to $15.65 per share, down from the prior $15.55 to $15.95 range given in July.

Management tied the guidance reduction to high-severity claims at Evry and a claims-processing delay at the Centers for Medicare and Medicaid Services that led to excess Medicare Supplement claims in the third quarter.

Globe Life also said it repurchased 1.1 million shares during the quarter for $185 million, but that capital return was not enough to offset the weaker outlook and the analyst downgrade.

Sources:

Globe Life Investor Relations, SEC, Reuters

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$GL Insider Trading Activity

$GL insiders have traded $GL stock on the open market 50 times in the past 6 months. Of those trades, 0 have been purchases and 50 have been sales.

Here’s a breakdown of recent trading of $GL stock by insiders over the last 6 months:

JAMES MATTHEW DARDEN (Co-Chairman & CEO) has made 0 purchases and 5 sales selling 76,682 shares for an estimated $13,226,704.
MICHAEL CLAY MAJORS (EVP - Chief Strategy Officer) has made 0 purchases and 5 sales selling 71,000 shares for an estimated $11,839,152.
THOMAS PETER KALMBACH (EVP & CFO) has made 0 purchases and 9 sales selling 66,489 shares for an estimated $11,468,621.
FRANK M SVOBODA (Co-Chairman & CEO) has made 0 purchases and 11 sales selling 65,000 shares for an estimated $10,290,505.
ROBERT BRIAN MITCHELL (EVP, General Counsel and CRO) has made 0 purchases and 5 sales selling 23,600 shares for an estimated $4,310,181.
ROBERT EDWARD HENSLEY (EVP & Chief Investment Officer) has made 0 purchases and 2 sales selling 10,000 shares for an estimated $1,700,701.
CHERYL ALSTON has made 0 purchases and 4 sales selling 8,258 shares for an estimated $1,480,134.
DOLORES L SKARJUNE (EVP and Chief Admin. Officer) has made 0 purchases and 4 sales selling 6,025 shares for an estimated $1,025,277.
MICHAEL SHANE HENRIE (SVP & Chief Accounting Officer) has made 0 purchases and 4 sales selling 5,741 shares for an estimated $888,824.
REBECCA E ZORN (EVP & Chief Talent Officer) sold 2,000 shares for an estimated $340,193

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive GL Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$GL Hedge Fund Activity

We have seen 307 institutional investors add shares of $GL stock to their portfolio, and 294 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 734,319 shares (+inf%) to their portfolio in Q2 2026, for an estimated $131,208,118
INVESCO LTD. added 602,869 shares (+15.0%) to their portfolio in Q2 2026, for an estimated $107,720,632
WELLINGTON MANAGEMENT GROUP LLP removed 561,683 shares (-42.4%) from their portfolio in Q2 2026, for an estimated $100,361,518
WOODLINE PARTNERS LP removed 353,588 shares (-96.6%) from their portfolio in Q2 2026, for an estimated $63,179,103
PZENA INVESTMENT MANAGEMENT LLC added 329,565 shares (+32.1%) to their portfolio in Q2 2026, for an estimated $58,886,674
AQR CAPITAL MANAGEMENT LLC added 318,085 shares (+26.6%) to their portfolio in Q2 2026, for an estimated $56,835,427
JPMORGAN CHASE & CO added 273,463 shares (+inf%) to their portfolio in Q2 2026, for an estimated $48,862,368

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$GL Price Targets

Multiple analysts have issued price targets for $GL recently. We have seen 4 analysts offer price targets for $GL in the last 6 months, with a median target of $200.5.

Here are some recent targets:

Wesley Carmichael from Wells Fargo set a target price of $193.0 on 07/09/2026
Bob Huang from Morgan Stanley set a target price of $208.0 on 07/06/2026
Andrew Kligerman from TD Cowen set a target price of $215.0 on 06/23/2026
John Barnidge from Piper Sandler set a target price of $175.0 on 05/26/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.